(Q38934344)

7 September 2017

Acute polyarthritis following the use of Corynebacterium parvum vaccine (Coparvax) for malignant pleural effusion (English)

1 reference

7 September 2017

Lever AM

1

1 reference

7 September 2017

Forsythe J

series ordinal

2

1 reference

7 September 2017

Oxford P

series ordinal

3

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 December 1983

1 reference

Postgraduate Medical Journal

7 September 2017

1 reference

7 September 2017

59

1 reference

7 September 2017

698

1 reference

7 September 2017

799-800

1 reference

Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions

7 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2417804

Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum

9 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2417804

Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvum

25 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6657546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6657546

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/PGMJ.59.698.799

1 reference

7 September 2017

1 reference

7 September 2017

PubMed publication ID

6657546

1 reference